Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal CancerAdam Lafferty, Alice C O'Farrell, Giorgia Migliardi, et al.
Science Advances|February 1, 2021
Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancerCatríona M Dowling, Kate E R Hollinshead, Alessandra Di Grande, et al.
Oncotarget|May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancerLinda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Neurobiology of Disease|August 18, 2020
Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsyGary P Brennan, Sebastian Bauer, Tobias Engel, et al.
BMC Biology|March 25, 2021
Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum couplingLuana Naia, Catarina M Pinho, Giacomo Dentoni, et al.
Iscience|May 1, 2026
Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosisKoen C Demaegd, Lindy Kool, Sharada Baindoor, et al.
Scientific Reports|June 20, 2020
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancerAna Barat, Dominiek Smeets, Bruce Moran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
A Stepwise Integrated Approach to Personalized Risk Predictions in Stage III Colorectal CancerManuela Salvucci, Maximilian L Würstle, Clare Morgan, et al.
Nature Communications|October 7, 2018
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapyDominiek Smeets, Ian S Miller, Darran P O'Connor, et al.
British Journal of Cancer|August 24, 2023
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkersIoannis Ntafoulis, Anne Kleijn, Jie Ju, et al.
Pageof 27